483
OrBion Pharmaceuticals Private LimitedOrBion Pharmaceuticals Private Limited – FDA 483, Sep 8, 2023
Record Details
During an inspection, Orbion Pharmaceuticals Private Limited in Sriperumbudur, India, was cited for three significant observations. These included failures in establishing adequate production and process controls, issues with equipment design and use, and non-adherence to established laboratory control mechanisms. The findings indicate deficiencies in ensuring drug product quality and manufacturing integrity.
View Company Profile
ID · b5f7d05a-7dad-40db-95aa-7bec1c6cb422
Other documents for OrBion Pharmaceuticals Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.